Previous Article | Next Article ![]()
Applied and Environmental Microbiology, March 2000, p. 904-908, Vol. 66, No. 3
Institute of Biotechnology, University of
Cambridge, Cambridge CB2 1QT, United Kingdom
Received 6 August 1999/Accepted 1 December 1999
A strain of Rhodococcus designated MB1, which was
capable of utilizing cocaine as a sole source of carbon and nitrogen
for growth, was isolated from rhizosphere soil of the tropane
alkaloid-producing plant Erythroxylum coca. A cocaine
esterase was found to initiate degradation of cocaine, which was
hydrolyzed to ecgonine methyl ester and benzoate; both of these
esterolytic products were further metabolized by
Rhodococcus sp. strain MB1. The structural gene encoding a
cocaine esterase, designated cocE, was cloned from Rhodococcus sp. strain MB1 genomic libraries by screening
recombinant strains of Rhodococcus erythropolis CW25 for
growth on cocaine. The nucleotide sequence of cocE
corresponded to an open reading frame of 1,724 bp that codes for a
protein of 574 amino acids. The amino acid sequence of cocaine esterase
has a region of similarity with the active serine consensus of X-prolyl
dipeptidyl aminopeptidases, suggesting that the cocaine esterase is a
serine esterase. The cocE coding sequence was subcloned
into the pCFX1 expression plasmid and expressed in Escherichia
coli. The recombinant cocaine esterase was purified to apparent
homogeneity and was found to be monomeric, with an
Mr of approximately 65,000. The apparent
Km of the enzyme (mean ± standard
deviation) for cocaine was measured as 1.33 ± 0.085 mM. These
findings are of potential use in the development of a linked assay for
the detection of illicit cocaine.
Tropane alkaloids, which possess a
characteristic azabicylo[3,2,1] octane system, represent one of the
most pharmacologically important groups among the alkaloids. In
particular, the tropane alkaloids exhibit anticholinergic and
anesthetic activities as well as parasympathetic inhibition. Cocaine is
the most well known of the tropane alkaloids and is a powerful central
nervous system stimulant and adrenergic blocking agent; its
hydrochloride salt is also used as a local surface anesthetic in face,
eye, nose, and throat operations. Cocaine is naturally located in the
leaves of coca plants (Erythroxylum spp.) and can be up to
1% of the dry weight content (13). Cocaine is, however, a
notorious drug of abuse and is considered to be one of the most
powerfully addictive drugs Western society has ever had to confront.
Illicit powder cocaine and crack cocaine are generally trafficked as
solid particulate matter, and much effort is currently being directed
at the development of sensors for drug detection. We envisaged that the
isolation of microorganisms from the environment capable of
metabolizing drugs, such as cocaine and heroin, as carbon sources for
growth might provide a good source of enzymes which could be utilized as recognition components in biosensors for the detection of illicit drugs. Previous work in our laboratory has shown that the enzymes initiating heroin metabolism in bacteria could be successfully used in
conjunction with bacterial luciferase for the detection of nanogram
quantities of heroin (5, 12, 24). Work has subsequently been
directed towards identifying appropriate enzymes active against
cocaine. A cocaine esterase was previously identified in a strain of
Pseudomonas maltophilia termed MB11L that was isolated from
a drug processing plant (4). P. maltophilia MB11L
was capable of utilizing cocaine as a sole source of carbon and energy for growth, and metabolism of cocaine was shown to be initiated by an
esterase that hydrolyzed cocaine to benzoate and ecgonine methyl ester
(Fig. 1). Unfortunately, the cocaine
esterase was unsuitable for biosensor development, as the enzyme was
observed in cell extracts either in an aggregated form or in
association with membrane components, and, as such, it proved extremely
difficult to purify.
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Gene Cloning and Nucleotide Sequencing and
Properties of a Cocaine Esterase from Rhodococcus sp.
Strain MB1
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

View larger version (8K):
[in a new window]
FIG. 1.
Cocaine esterase reaction.
We report here the isolation of a strain of Rhodococcus that can utilize cocaine as a sole source of carbon and nitrogen for growth and the cloning, sequencing, and properties of a soluble cytosolic cocaine esterase.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Organisms, plasmids, and growth conditions. Rhodococcus sp. strain MB1 was isolated from soil samples collected from the rhizosphere of coca plants and on the basis of its ability to utilize cocaine as a sole source of carbon. The enrichment conditions and growth conditions were as described by Britt et al. (4). Escherichia coli JM109 was obtained from Promega (Southampton, Hampshire, United Kingdom [U.K.]) and was grown according to standard procedures (26). Epicurian Coli XL1-Blue MR was obtained from Stratagene (Cambridge, U.K.). Rhodococcus erythropolis CW25 and the E. coli-Rhodococcus shuttle vector pDA71 were kind gifts from E. Dabbs (University of the Witwatersrand, Johannesburg, South Africa). pCFX1 is an expression vector derived from pBluescript SK(+) by the insertion of the promoter region of pONR (9).
Reagents. Cocaine hydrochloride was purchased from Macfarlan Smith Ltd. (Edinburgh, Scotland, U.K.). Ecgonine methyl ester was synthesized from cocaine as described previously (17). Other reagents were of analytical or higher grade.
DNA manipulation.
All restriction enzymes were purchased
from New England Biolabs (Hitchin, U.K.) and used according to the
manufacturer's protocols. Southern blotting and cloning procedures
were performed according to standard methods (26).
Rhodococcal strains were transformed by electroporation and were
rendered electrocompetent via the method used by Kesseler et al.
(14). The transformations were conducted using a protocol
adapted from those of Desomer et al. (7) and Andersen et al.
(2). Cells were grown to exponential phase in a rich
Luria-Bertani (LB) medium supplemented with 1.8% (wt/vol) sucrose and
1.5% (wt/vol) glycine. The cells were cooled on ice, harvested by
centrifugation, and washed with ice-cold distilled H2O
prior to resuspension in 30% (wt/vol) polyethylene glycol 8000, concentrating the cells 100-fold. Aliquots of cells (100 µl) were
used directly in transformations with the addition of up to 1 µg of
DNA, mixing, and incubation on ice for 10 min in 0.2-cm electroporation
cuvettes. Cells were electroporated in a Gene Pulser (Bio-Rad
Laboratories, Hercules, Calif.) with a capacitance of 25 µF, voltage
of 2.5 kV, and resistance of 400
to achieve a time constant of more
than 7.5 ms. The cells were incubated at 30°C for 3 h in 1 ml of
LB medium lacking antibiotic, which allowed phenotypic expression
before plating onto LB or minimal medium plates containing 34 µg of
chloramphenicol per ml to select for transformants containing pDA71.
Determination of 16S rDNA sequence. Primers fD1 and rD1 were designed around the 5' and 3' ends of bacterial 16S ribosomal DNA (rDNA), respectively, to produce an approximately 1.5-kb fragment of 16S rDNA from bacteria by PCR amplification (29). The annealing temperature was 42°C. The primers had the following sequences: fD1, 5'-CCGAATTCGTCGACAACAGAGTTTGATCCTGGCTCAG-3'; rD1, 5'-CCCGGGATCCAAGCTTAAGGAGGTGATCCAGCC-3'. The 1.5-kb PCR product amplified from the isolate was gel purified and subjected to direct PCR sequencing using the primer fD1. The DNA sequence obtained was submitted to biological databases for comparison with other 16S rDNAs. The GenBank, EMBL, DDBJ, and PDB databases were searched using the BLASTN search on the National Center for Biological Information website (1).
Construction of genomic libraries.
To prepare genomic DNA
fragments of approximately 5 to 10 kb, genomic DNA (100 µg) from
Rhodococcus strain MB1 was subjected to partial digestion
with Sau3AI and fractionated on a linear 10 to 40% sucrose
density gradient. Fractions containing DNA fragments of the desired
size were pooled and ligated into the E. coli-Rhodococcus shuttle vector pDA71. The plasmid DNA was transformed into the supercompetent E. coli (Epicurian Coli XL1-Blue MR) and into
R. erythropolis CW25 by electroporation. In the case of both
the E. coli and Rhodococcus libraries, colonies
were washed off selective plates under sterile conditions using LB
medium containing 15% glycerol (vol/vol) and stored at
80°C.
Cloning of cocE into an expression host. cocE was subcloned by PCR. The primers used were as follows (the bases corresponding to introduced restriction sites NdeI and HindIII, respectively, are shown in bold): forward, CAG CGA AGG TCG GGA GCA TAT GGT GGA CGG G; reverse, TTT AAG CTT CAG CGT CAG CCA GGC GCG GCT GC. PCR was performed with BioTaq polymerase. The annealing temperature was 67°C. The product was digested with NdeI and HindIII and ligated into pCFX1 cut with the same enzymes to yield pCOC2.
Protein sequence comparisons. Protein sequence comparisons were performed using the software package MACAW (version 2.05; National Center for Biotechnology Information, National Library of Medicine, Bethesda, Md.) and the BLOSUM62 matrix (11).
Reverse-phase HPLC for analysis of the breakdown of cocaine. Samples were separated by reverse-phase high-pressure liquid chromatography (HPLC) using a model 1050 component system with a multiple wavelength detector (Hewlett-Packard, Waldbronn, Germany) on a Techsphere 5 ODS column (0.46 by 25 cm, 5-µm particles) (HPLC Technology Co. Ltd., Macclesfield, Cheshire, U.K.). The mobile phase consisted of a gradient system comprising an organic phase of methanol and an aqueous phase which contained 1% (wt/vol) glacial acetic acid-50 mM pentane sulfonic acid, adjusted to pH 6.9 with ammonia (d = 0.88). Compounds were detected at 228 nm. After application of the sample, the gradient was started with 3% organic phase, which was increased linearly to 84% from 3 to 6 min, where it was held for a further 8 min before being decreased to 3% between 14 and 20 min.
TLC for analysis of the breakdown of cocaine. Thin-layer chromatography (TLC) of cocaine and its metabolites was performed using 200-µm polyester plates precoated with UV-absorbing silica gel (Macherey-Nagel, Düren, Germany). The samples (10 µl) were developed with a mobile phase of ethylacetate-methanol-ammonia (13:7:1 [vol/vol/vol]; adapted from the method of Mira et al. [20]). Compounds were detected on the basis of their UV absorbance at 254 nm and color formation when sprayed with Ludy Tenger reagent (21). Relative migration distances of compounds detected in samples were compared with those of authentic cocaine, benzoate, benzoylecgonine, and ecgonine methyl ester standards.
Purification of cocaine esterase from recombinant E. coli.
E. coli (JM109) carrying pCOC2 was grown until stationary
phase on SOB medium (26) containing 100 µg of ampicillin
per ml and 0.5 mM isopropyl-
-D-thiogalactopyranoside
(IPTG) at 37°C. Cells were pelleted by centrifugation at
10,000 × g and resuspended in 100 mM Tris-HCl at pH
7.5. A cell extract was prepared by sonication of the cells on ice (12 bursts of 15 s at an amplitude of 12 µm), followed by
centrifugation of the extract at 20,000 × g for 15 min
before ultracentrifugation at 100,000 × g for 60 min.
Ammonium sulfate was slowly added to the extract on ice, to a final
concentration of 1.25 M. Precipitated protein was removed by
centrifugation at 12,000 × g, and the supernatant,
which contained the cocaine esterase activity, was further purified by
hydrophobic-interaction chromatography. A phenyl-Sepharose CL-4B column
(100-ml bed volume; Amersham Pharmacia Biotech Ltd., St. Albans,
Hertfordshire, U.K.) was run at 2 ml/min and equilibrated with 1.25 M
ammonium sulfate-100 mM Tris-HCl at pH 7.5 before the protein solution
was applied. Protein was eluted by decreasing the ammonium sulfate
concentration from 0.63 to 0 M over 300 ml, followed by addition of 200 ml of 100 mM Tris-HCl at pH 7.5. Activity-containing fractions from the
column were pooled and dialyzed against two 5-liter volumes of 100 mM
Tris-HCl at pH 7.5. The dialyzed protein was applied to a Fast Flow Q
Sepharose column run at 1 ml/min (80-ml bed volume; Amersham Pharmacia
Biotech Ltd.). The column had been previously equilibrated with 100 mM
Tris-HCl at pH 7.5 before the protein was applied. A 500-ml NaCl
gradient from 0 to 0.6 M was used to elute bound protein. Fractions
that contained cocaine esterase activity were pooled and were dialyzed
against two 5-liter volumes of 5 mM KH2PO4 at
pH 7.5. The protein was then loaded onto a Bio-Gel HT hydroxylapatite
column run at 0.5 ml/min (12-ml bed volume; Bio-Rad Laboratories). The
column had been preequilibrated with 5 mM
KH2PO4 at pH 7.5. After the sample was loaded,
the phosphate concentration was increased to 120 mM over 60 ml, during
which time the majority of the bound protein was eluted.
Activity-containing fractions from the column were pooled and dialyzed
against two 2-liter volumes of 100 mM Tris-HCl buffer-100 mM NaCl at
pH 7.5. The dialyzed protein was loaded onto a prepacked Resource Q
column (6-ml column bed volume; Amersham Pharmacia Biotech Ltd.) at a flow rate of 1 ml/min. The column had been preequilibrated with 100 mM
Tris-HCl buffer-100 mM NaCl at pH 7.5. A linear sodium chloride
gradient from 250 to 400 mM over 132 ml was used to elute the esterase.
Fractions containing the cocaine esterase were then pooled.
Estimation of the native molecular weight of the cocaine esterase. The native molecular weight of the purified cocaine esterase was determined by gel filtration chromatography using a prepacked Superose 6 HR column (Amersham Pharmacia Biotech Ltd.). The column was equilibrated with 100 mM Tris-HCl-100 mM NaCl at pH 7.5 and calibrated using a low-molecular-weight calibration kit (Amersham Pharmacia Biotech Ltd.).
Enzyme assays. Cocaine esterase activity was measured by quantifying the amount of benzoate produced from cocaine by reverse-phase HPLC. The standard assay conditions were 100 mM Tris-HCl at pH 7.5, with 10 mM cocaine in a total volume of 100 µl incubated at 30°C. All assay results were compared with those from control assays containing no extract and extract boiled for 5 min to denature the enzyme. For a given cocaine concentration, five assays were set up and incubated at 30°C and stopped at 1-min intervals by the addition of 100 µl of 1 M HCl. The specific activity was expressed in units of cocaine esterase per milligram of total protein, where 1 U of cocaine esterase was defined as the amount required to produce 1 µmol of benzoate per min under these conditions. Assays involving atropine were performed under the same conditions with samples taken after 15, 30, 90, and 180 min. Km and Vmax were determined using 0.24 µg (44 U/mg) of cocaine esterase and varying the cocaine concentration between 0.15 and 30 mM. Samples were assayed over a period of 5 min. Kinetic equations were fitted to data using the GraFit 3 software package (Erithacus Software Limited, Middlesex, U.K.).
Nucleotide sequence accession number. The nucleotide sequence data reported have been submitted to GenBank and assigned the accession number AF173165.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Isolation of Rhodococcus sp. strain MB1. As cocaine is a natural compound, we considered it likely that microorganisms that had evolved the ability to metabolize cocaine as a carbon source would exist in close proximity to cocaine-producing coca plants. We therefore carried out selective enrichments with soil samples taken from the rhizosphere of coca plants in defined liquid medium, which resulted in the isolation of a bacterium, designated strain MB1, that could utilize cocaine as the sole carbon and nitrogen source for growth. Analysis of the culture broth by TLC and HPLC showed the disappearance of cocaine and the transient accumulation of ecgonine methyl ester and benzoate (data not shown); both of these metabolites supported growth of the bacterium when supplied in minimal medium as a sole carbon source, while ecgonine methyl ester could also be utilized as a source of nitrogen.
Strain MB1 was found to be a gram-positive, rod-forming bacterium. A partial (500-bp) 16S rDNA sequence was obtained for strain MB1, and comparative phylogenetic analysis of the sequences revealed that strain MB1 clustered closely with species entirely from the mycolic acid-containing nocardioform actinomycetes. The highest scoring match was to the 16S rDNA of Rhodococcus equi strain DSM 20307T (accession number X80614), to which the DNA from MB1 displayed 95.8% sequence similarity. On the basis of the phylogenetic analysis, organism MB1 was identified as a species of the genus Rhodococcus.Cocaine esterase. Extracts from cells grown on 5 mM cocaine were found to possess a cytosolic cocaine esterase with a specific activity of 0.15 U/mg that hydrolyzed cocaine to benzoate and ecgonine methyl ester (Fig. 1). This activity was found to be inducible in Rhodococcus sp. strain MB1, since no cocaine esterase activity was observed in cells grown on 15 mM succinate as a sole source of carbon.
Cloning and sequencing of cocE.
In order to obtain
significant quantities of biomass for enzyme purification and
characterization studies, prohibitive quantities of cocaine were
required as a growth substrate; therefore, it was decided to clone the
gene encoding the cocaine esterase activity and express it in E. coli. The cloning strategy was to construct genomic libraries of
MB1 using the E. coli-Rhodococcus shuttle vector pDA71. The
libraries were then transformed into a rhodococcal host strain,
R. erythropolis CW25, which is capable of growth on benzoate
but not on cocaine. Expression of a cocaine esterase gene was selected
for by screening recombinant strains of R. erythropolis CW25
for growth on cocaine as the sole carbon source. This procedure yielded
eight clones that were capable of slowly hydrolyzing cocaine to
benzoate and ecgonine methyl ester; the benzoate was further metabolized as a growth substrate by the clones. All the
cocaine-degrading clones contained an identical 2.7-kb fragment in the
recombinant plasmid designated pCOC1. Sequencing of the inserted
fragment indicated the presence of an open reading frame encoding a
polypeptide of 574 amino acids from which the theoretical molecular
mass of the protein was calculated to be 62,128 Da. Cell extracts of
R. erythropolis CW25 as well as extracts prepared from
E. coli JM109 harboring the construct pCOC1 displayed low
levels of cocaine esterase activity (4.8 × 10
3 and
1.5 × 10
3 U/mg, respectively). This evidence, taken
together with the sequence analysis (see below), supports the
suggestion that cocE encoded the cocaine esterase.
10 and
35 promoter regions
were detected in the upstream EcoRI DNA (data not shown)
that may be responsible for the low levels of expression in E. coli JM109.
Sequence comparisons of CocE with other related sequences.
The
deduced amino acid sequence was used for homology searches with a range
of biological databases, and it was found that CocE was related to a
number of prokaryotic enzymes. The closest match was to a glutaryl
7-aminocephalosporanic acid acylase enzyme from Bacillus
laterosporus J1, which converts glutaryl 7-aminocephalosporanic acid to 7-aminocephalosporanic acid through the cleavage of an acyl
linkage (3). The two proteins exhibit 37.2% sequence
identity and 46.7% sequence similarity. Their similarity is
illustrated by an alignment of the amino acid sequences (Fig.
2). The other high-scoring matches on the
protein level were three hypothetical proteins of unknown function from
Mycobacterium and five matches to X-prolyl dipeptidyl
aminopeptidase enzymes from Lactococcus lactis and
Lactobacillus spp. (Fig. 3),
but the homology to these protein sequences was over a significantly
smaller region (approximately 60 residues [18, 19, 23, 27,
30]). On average, a sequence identity of 39% and a sequence
similarity of 50% with the dipeptidyl aminopeptidases were displayed
over this region. The X-prolyl dipeptidyl aminopeptidases have amidase
and esterase activities in addition to peptidase activities
(29). These enzymes are serine proteases, and the consensus
sequence surrounding the active-site serine has been identified as
G-X-S-Y-X-G, where X is a nonconserved amino acid (6). The
sequence of CocE shows conservation of sequence with the X-prolyl
dipeptidyl aminopeptidases from L. lactis and
Lactobacillus spp. around the active-site serine, suggesting that cocE encodes a serine esterase (Fig. 3).
|
|
Expression of cocE in E. coli. High levels of expression of cocE were achieved by subcloning the cocE coding region, obtained by PCR, into pCFX1 to yield pCOC2. Cell extracts of recombinant E. coli were found to contain cocaine esterase activity with a specific activity of 0.13 U/mg of protein.
In order to characterize the recombinant cocaine esterase, the enzyme was purified 350-fold to homogeneity, as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Fig. 4); it possessed a specific activity of 44 U/mg (Table 1). The native molecular mass of the purified esterase was determined by gel filtration to be approximately 65,000 Da. This value is consistent with the subunit molecular weight of the cocaine esterase, as determined by SDS-PAGE and through translation of cocE, which suggests that active cocaine esterase exists as a monomer. The apparent Km (mean ± standard deviation) of the enzyme was found to be 1.33 ± 0.085 mM. The cocaine esterase displayed low levels of activity (2.1 U/mg) with 20 mM atropine, a structurally related tropane alkaloid. Interestingly, bacterial atropine esterases do not display any activity against cocaine (25), while an esterolytic activity from a strain of P. maltophilia that was isolated from industrial waste liquors was shown to display activity against cocaine but not atropine (4). The N-terminal sequence of the first 11 amino acid residues of the purified protein was determined, and it was found to match the deduced amino acid sequence of cocaine esterase (CocE).
|
|
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Leverhulme Trust and the BBSRC.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute of Biotechnology, University of Cambridge, Tennis Court Rd., Cambridge CB2 1QT, United Kingdom. Phone: 44 (0) 1223 334168. Fax: 44 (0) 1223 334162. E-mail: n.bruce{at}biotech.cam.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Altschul, S. F., W. Gish, W. Miller, E. W. Meyers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410[CrossRef][Medline]. |
| 2. | Andersen, S. J., S. Quan, B. Gowan, and E. R. Dabbs. 1997. Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic. Antimicrob. Agents Chemother. 41:218-221[Abstract]. |
| 3. |
Aramori, I.,
M. Fukagawa,
M. Tsumura,
M. Iwami,
H. Ono,
H. Kojo,
M. Kohsaka,
Y. Ueda, and H. Imanaka.
1991.
Cloning and nucleotide sequencing of a novel 7 -(4-carboxybutanamido)cephalosporanic acid acylase gene of Bacillus laterosporus and its expression in Escherichia coli and Bacillus subtilis.
J. Bacteriol.
173:7848-7855 |
| 4. |
Britt, A. J.,
N. C. Bruce, and C. R. Lowe.
1992.
Identification of a cocaine esterase in a strain of Pseudomonas maltophilia.
J. Bacteriol.
174:2087-2094 |
| 5. |
Cameron, G. W. W.,
K. N. Jordan,
P.-J. Holt,
P. B. Baker,
C. R. Lowe, and N. C. Bruce.
1994.
Identification of a heroin esterase in Rhodococcus sp. strain H1.
Appl. Environ. Microbiol.
60:3881-3883 |
| 6. | Chich, J. F., M. P. Chapot-Chartier, B. Ribadeau-Dumas, and J. C. Gripon. 1992. Identification of the active-site serine of the X-prolyl dipeptidyl aminopeptidase from Lactococcus lactis. FEBS Lett. 314:139-142[CrossRef][Medline]. |
| 7. |
Desomer, J.,
P. Dhaese, and M. Van Montagu.
1990.
Transformation of Rhodococcus fascians by high-voltage electroporation and development of R. fascians cloning vectors.
Appl. Environ. Microbiol.
56:2818-2825 |
| 8. | Desomer, J., D. Vereecke, M. Crespi, and M. van Montagu. 1992. The plasmid-encoded chloramphenicol-resistance protein of Rhodococcus fascians is homologous to the transmembrane tetracycline efflux proteins. Mol. Microbiol. 6:2377-2385[Medline]. |
| 9. |
French, C. E.,
S. Nicklin, and N. C. Bruce.
1996.
Sequence and properties of pentaerythritol tetranitrate reductase from Enterobacter cloacae PB2.
J. Bacteriol.
178:6623-6627 |
| 10. | Grzeszik, C., M. Lubbers, M. Reh, and H. G. Schlegel. 1997. Genes encoding the NAD-reducing hydrogenase of Rhodococcus opacus MR11. Microbiology 143:1271-1286[Abstract]. |
| 11. |
Heikoff, S., and J. G. Heikoff.
1992.
Amino acid substitution matrices from protein blocks.
Proc. Natl. Acad. Sci. USA
89:10915-10919 |
| 12. | Holt, P. J., N. C. Bruce, and C. R. Lowe. 1996. Bioluminescent assay for heroin and its metabolites. Anal. Chem. 68:1877-1882[Medline]. |
| 13. | Johnson, E. L. 1996. Alkaloid content in Erythroxylum coca tissue during reproductive development. Phytochemistry 42:35-38[CrossRef]. |
| 14. | Kesseler, M., E. R. Dabbs, B. Averhoff, and G. Gottschalk. 1996. Studies on the isopropylbenzene 2,3-dioxygenase and the 3-isopropylcatechol 2,3-dioxygenase genes encoded by the linear plasmid of Rhodococcus erythropolis BD2. Microbiology 142:3241-3251[Abstract]. |
| 15. |
Komeda, H.,
Y. Hori,
M. Kobayashi, and S. Shimizu.
1996.
Transcriptional regulation of the Rhodococcus rhodochrous J1 nitA gene encoding a nitrilase.
Proc. Natl. Acad. Sci. USA
93:10572-10577 |
| 16. |
Li, M. Z.,
C. H. Squires,
D. J. Monticello, and J. D. Childs.
1996.
Genetic analysis of the dsz promoter and associated regulatory regions of Rhodococcus erythropolis IGTS8.
J. Bacteriol.
178:6409-6418 |
| 17. | Lister, D. L., R. F. Sproule, A. J. Britt, C. R. Lowe, and N. C. Bruce. 1996. Degradation of cocaine by a mixed culture of Pseudomonas fluorescens MBER and Comamonas acidovorans MBLF. Appl. Environ. Microbiol. 62:94-99[Abstract]. |
| 18. |
Mayo, B.,
J. Kok,
K. Venema,
W. Bockelmann,
M. Teuber,
H. Reinke, and G. Venema.
1991.
Molecular cloning and sequence analysis of the X-prolyl dipeptidyl aminopeptidase gene from Lactococcus lactis subsp. cremoris.
Appl. Environ. Microbiol.
57:38-44 |
| 19. | Meyer-Barton, E. C., J. R. Klein, M. Imam, and R. Plapp. 1993. Cloning and sequence-analysis of the X-prolyl dipeptidyl-aminopeptidase gene (Pepx) from Lactobacillus delbrueckii ssp. lactis DSM 7290. Appl. Microbiol. Biotechnol. 40:82-89[Medline]. |
| 20. | Mira, A. L., R. B. Pontani, and S. J. Mule. 1973. Separation of cocaine, some of its metabolites and congeners on glass fibre sheets. J. Chromatogr. 81:167-169[CrossRef][Medline]. |
| 21. | Moffat, A. C. 1986. Clarke's isolation and identification of drugs, 2nd ed. The Pharmaceutical Press, London, England. |
| 22. |
Nagy, I.,
G. Schoofs,
F. Compernolle,
P. Proost,
J. Vanderleyden, and R. De Mot.
1995.
Degradation of the thiocarbamate herbicide EPTC (S-ethyl dipropylcarbamothioate) and biosafening by Rhodococcus sp. strain NI86/21 involve an inducible cytochrome P-450 system and aldehyde dehydrogenase.
J. Bacteriol.
177:676-687 |
| 23. |
Nardi, M.,
M.-C. Chopin,
A. Chopin,
M.-M. Cals, and J.-C. Gripon.
1991.
Cloning and DNA sequence analysis of an X-prolyl dipeptidyl aminopeptidase gene from Lactococcus lactis subsp. lactis NCDO 763.
Appl. Environ. Microbiol.
57:45-50 |
| 24. | Rathbone, D. A., P. J. Holt, C. R. Lowe, and N. C. Bruce. 1996. The use of a novel recombinant heroin esterase in the development of an illicit drugs biosensor. Ann. N. Y. Acad. Sci. 799:90-96[Medline]. |
| 25. | Rorsch, A., F. Berends, H. C. Bartlema, and W. F. Stevens. 1971. The isolation and properties of Pseudomonas strains growing on atropine and producing an atropine esterase. Proc. K. Ned. Akad. Wet. Ser. C 74:132-147. |
| 26. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 27. | Vesanto, E., K. Savijoki, T. Rantanen, J. L. Steele, and A. Palva. 1995. An X-prolyl dipeptidyl aminopeptidase (Pepx) gene from Lactobacillus helveticus. Microbiology 141:3067-3075[Abstract]. |
| 28. |
Weisburg, W. G.,
S. M. Barns,
D. A. Pelletier, and D. J. Lane.
1991.
16S ribosomal DNA amplification for phylogenetic study.
J. Bacteriol.
173:697-703 |
| 29. | Yoshpe-Besancon, I., J. C. Gripon, and B. Ribadeau-Dumas. 1994. Xaa-Pro dipeptidyl aminopeptidase from Lactococcus lactis catalyzes kinetically controlled synthesis of peptide bonds involving proline. Biotechnol. Appl. Biochem. 20:131-140. |
| 30. | Yüksel, G. U., and J. L. Steele. 1996. DNA sequence analysis, expression, distribution, and physiological role of the Xaa-prolyl dipeptidyl aminopeptidase gene from Lactobacillus helveticus CNRZ32. Appl. Microbiol. Biotechnol. 44:766-773[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|